Literature DB >> 2590380

Targeted cancer treatment.

D M Goldenberg.   

Abstract

The fourth international conference on monoclonal antibody immunoconjugates for cancer heard of great progress in the area of radioimmunoconjugates, and of continued research into the potential of immunotoxins, chemoimmunoconjugates and anti-immunoglobulin therapy as potential cancer therapies.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2590380     DOI： 10.1016/0167-5699(89)90082-0

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  2 in total

1.  Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates.

Authors:  Vishwesh Patil; Keyur Gada; Rajiv Panwar; Alexandra Varvarigou; Stan Majewski; Andrew Weisenberger; Craig Ferris; Yared Tekabe; Ban-An Khaw
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05       Impact factor: 9.236

Review 2.  Bispecific antibody: a tool for diagnosis and treatment of disease.

Authors:  S Songsivilai; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.